## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report that the ABCA1 R230C variant, associated with low plasma HDL-C, preserves tertiary fold but alters dynamics and membrane coupling in 200 ns molecular dynamics simulations, leading to disrupted cholesterol transport pathway and providing a biophysical rationale for reduced efflux.
- **Visible evidence base** Abstract text only; no numerical data, simulation parameters, analysis details, or validation metrics provided
- **Missing materials affecting confidence** Full methods, simulation setup details, force field parameters, convergence criteria, all figures and tables, statistical analyses, and any validation or control simulations

## Reviewer
- **Overall assessment** The abstract presents a plausible and mechanistically interesting hypothesis that R230C acts as a dynamic allosteric modulator rather than a fold-disrupting mutation. However, the evidence base visible in the abstract is insufficient to evaluate the technical rigor of the simulations, the statistical significance of the reported differences, or the robustness of the conclusions. The claims are broad relative to the limited methodological detail disclosed.
- **Who would be interested in the results, and why** Researchers in lipid metabolism, HDL biology, and membrane transporter biophysics would be interested. The work addresses a clinically relevant variant with a clear phenotype (low HDL-C) and proposes a mechanistic explanation at atomic resolution, which could inform future functional studies and therapeutic strategies targeting ABCA1.
- **Major strengths** The study addresses a clinically relevant variant with an unresolved mechanism. The use of multiple complementary analyses (RMSD, RMSF, Rg, SASA, MOSAICS, CAVER) suggests a comprehensive approach. The conclusion that the variant acts as a dynamic modulator rather than a folding-disruptive mutation is a nuanced and potentially valuable distinction.
- **Major Concerns**
  - **Concern ID** R1-M1
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Technical soundness
  - **Claim pointer** The abstract claims that 200 ns simulations reveal structural and dynamic differences between R230C and WT ABCA1 that explain reduced cholesterol efflux.
  - **Evidence pointer** Abstract only; location not provided
  - **Concern** The abstract provides no information on simulation convergence, replicate numbers, force field selection, or system equilibration. A 200 ns timescale for a large membrane protein such as ABCA1 is generally considered short for drawing definitive conclusions about conformational dynamics, particularly for allosteric effects involving distal domains.
  - **Why it matters** Without evidence of convergence and adequate sampling, the reported differences in RMSD, RMSF, Rg, and SASA could reflect insufficient sampling rather than genuine biophysical differences. The claim that distal domains (NBD2, TMD2) show altered dynamics due to a local mutation requires robust statistical support.
  - **Resolution test** Provide convergence plots, replicate simulations with error bars, and a demonstration that the observed differences exceed simulation noise. If replicates are not available, justify the single-trajectory approach and provide block-averaging or other statistical measures.
  - **Concern ID** R1-M2
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Technical soundness
  - **Claim pointer** The abstract states that CAVER analysis demonstrated increased pathway heterogeneity (17 clusters vs. 10), lower persistence, and smaller bottleneck radii, disrupting the primary cholesterol transport route.
  - **Evidence pointer** Abstract only; location not provided
  - **Concern** The abstract reports cluster counts and bottleneck radii without any statistical context. It is unclear whether these differences are significant, reproducible across replicates, or sensitive to analysis parameters. The functional interpretation that this "disrupts" the transport route is an inference that requires structural and dynamic evidence linking tunnel properties to cholesterol efflux.
  - **Why it matters** The central mechanistic claim rests on the CAVER results. If the differences are within noise or parameter sensitivity, the conclusion that R230C disrupts the transport route is unsupported.
  - **Resolution test** Provide statistical comparisons (e.g., distributions of bottleneck radii across frames and replicates), sensitivity analysis for CAVER parameters, and a clear definition of "persistence" and "disruption" with quantitative thresholds.
  - **Concern ID** R1-M3
  - **Severity** Major
  - **Blocking** No
  - **Axis** Scientific importance
  - **Claim pointer** The abstract claims that R230C acts as a "dynamic allosteric modulator and membrane-coupling agent" providing a "biophysical rationale for reduced cholesterol efflux and low plasma HDL-C levels."
  - **Evidence pointer** Abstract only; location not provided
  - **Concern** The abstract does not connect the simulation findings to functional data. No experimental validation (e.g., efflux assays, cell-based studies) is mentioned, and the link between the observed dynamic changes and the clinical phenotype is purely inferential.
  - **Why it matters** The claim of providing a "biophysical rationale" for a clinical phenotype requires at least a plausible and well-supported mechanistic chain. Without functional correlation, the clinical relevance of the simulation findings remains speculative.
  - **Resolution test** Include or cite functional data linking R230C to reduced efflux, or clearly frame the simulation results as hypothesis-generating rather than explanatory. If functional data exist elsewhere, reference them explicitly.
- **Minor Comments**
  - **Concern ID** R1-m1
  - **Severity** Minor
  - **Axis** Readability for nonspecialists
  - **Affected element** Abstract text
  - **Evidence pointer** Abstract; location not provided
  - **Issue** Terms such as "MOSAICS analysis" and "CAVER tunnel analysis" are used without brief explanation of what they measure, which may hinder nonspecialist readers.
  - **Required correction** Add a brief parenthetical description of each method (e.g., "membrane property analysis" and "channel/tunnel detection") in the abstract or ensure the full text provides accessible introductions.
  - **Concern ID** R1-m2
  - **Severity** Minor
  - **Axis** Technical soundness
  - **Affected element** Simulation timescale
  - **Evidence pointer** Abstract; location not provided
  - **Issue** The abstract states "200 ns molecular dynamics simulations" without justifying this timescale for the system under study.
  - **Required correction** Briefly justify the timescale choice in the abstract or methods, or acknowledge its limitations in capturing slow conformational transitions.
  - **Concern ID** R1-m3
  - **Severity** Minor
  - **Axis** Scientific importance
  - **Affected element** Clinical relevance framing
  - **Evidence pointer** Abstract; location not provided
  - **Issue** The abstract implies a direct link between simulation findings and "low plasma HDL-C levels" without acknowledging the complexity of HDL metabolism and the many factors influencing plasma HDL-C.
  - **Required correction** Soften the causal language or add a sentence acknowledging that the simulation provides a structural hypothesis that requires integration with physiological data.
- **Technical failings that need to be addressed before the case is established** R1-M1 (simulation convergence and sampling), R1-M2 (statistical robustness of CAVER results). These are blocking because the core mechanistic claims depend on the reliability of the dynamic and tunnel analyses.
- **Assessment against Nature-style criteria**  
  Originality: The idea that R230C acts as a dynamic allosteric modulator rather than a fold-disrupting mutation is somewhat novel and could be of interest. However, the abstract does not clearly differentiate this from prior studies on ABCA1 variants.  
  Scientific importance: The clinical relevance of ABCA1 and HDL-C is high, but the abstract does not establish that the simulation findings translate to functional outcomes. The importance is therefore potential rather than demonstrated.  
  Interdisciplinary readership: The work bridges structural biology, biophysics, and lipid metabolism, which could attract a broad audience. However, the abstract assumes familiarity with simulation and tunnel analysis methods.  
  Technical soundness: Not assessable from the abstract alone. The lack of methodological detail and statistical context prevents evaluation of the reliability of the results.  
  Readability for nonspecialists: The abstract is generally clear but uses specialized terms without explanation, which may limit accessibility.
- **Recommendation posture** Currently not established from the provided evidence. The hypothesis is interesting and the approach is comprehensive, but the abstract does not provide sufficient technical detail to assess the validity of the simulation results or the strength of the mechanistic claims. Supportive if the full manuscript addresses the convergence, sampling, and statistical concerns, and if the link to functional outcomes is either demonstrated or appropriately qualified.

## Risk / unsupported claims
- The claim that R230C "disrupts the primary cholesterol transport route" is unsupported without statistical evidence for the CAVER differences and a demonstrated link between tunnel properties and efflux function.
- The claim that R230C provides a "biophysical rationale for reduced cholesterol efflux and low plasma HDL-C levels" is unsupported in the abstract, as no functional or clinical data are presented.
- The claim of "reduced overall flexibility" and "slightly expanded conformation" is not assessable without numerical values, error estimates, or replicate information.
- The claim that changes in distal domains (NBD2, TMD2) are "coupled" to the local mutation is not supported by any correlation or communication pathway analysis described in the abstract.